This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
But increased competition is on the horizon. Sodium oxybate — which in the late 1980s was marketed to bodybuilders and then became known as GHB and criminally used as a date rape drug — has been sold under the brand name Xyrem after gaining FDA approval in 2002. Competition starts to heat up. Classic treatment options.
Best For: Targeting verified HCPs in a compliant and specialized environment. Competitive Keywords: Terms related to rival brands, helping capture market share. Follow FDA and Regulatory Guidelines Ensure all PPC ads adhere to FDA, EMA, or MHRA regulations. Avoiding misleading claims that exaggerate efficacy or safety.
Strict guidelines from the Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) require marketers to ensure transparency and accuracy in all communications. FDA Guidelines and Promotional Review Committees Understanding FDA regulations is critical for all pharma marketing professionals.
In todays competitive market, where digital strategies and patient-centric approaches are essential, having an expert partner is more critical than ever. With their specialized expertise, they understand the complex regulatory environment and can craft campaigns that resonate with your target audience while staying compliant.
But how does it work, and how can you make the most of it in the competitive pharmaceutical industry? Example: If promoting Jardiance for diabetes management, focus on unique selling points like proven efficacy and FDA approval. Ensure your ads comply with FDA guidelines. PPC does just that. Let’s dive into the essentials.
In a competitive healthcare economy, knowing how to thrive digitally is just as important as the science behind the product. Companies like eHealthcare Solutions specialize in targeted advertising across endemic medical sites, offering both reach and relevance. Transparency and fair balance remain non-negotiable.
These iterative processes can delay product launches and increase overall expenses, making it difficult to stay competitive in a fast-paced market. This approach allowed them to perfect the design in just 7-10 iterations, ultimately speeding up the process of gaining FDA approval.
Since the inception of the clinical specialization, the orthopedic industry has relied on reusable surgical instrumentation. Quite recently, the Food and Drug Administration (FDA) marked a historical moment when it approved Patient Specific Talus Spacer 3D-printed implants in 2021. However, some specific trends demand a closer look.
Platforms like eHealthcare Solutions offer specialized digital advertising solutions designed for pharma brands, ensuring compliance while maximizing reach and engagement. Regulatory frameworks such as HIPAA, GDPR, and FDA guidelines dictate how pharmaceutical brands can advertise and engage with healthcare professionals (HCPs) and patients.
You need a marketing strategy that sets your medical device apart from the competition. Food & Drug Administration (FDA) classifies medical devices. How the FDA Classifies Medical Devices. The FDA classifies medical devices into one of three classes based on their risks and regulatory controls: .
However, new MS drugs like Novartis ’ Gilenya, were going to soon enter the market and increase competition within the MS therapeutic landscape. Ferry explains, “The government deems that [special fraud alert] as public notice to the industry that they are concerned about these public programs.”.
The FDA’s recent approval of TG Therapeutics’s Briumvi (ublituximab) against relapsing forms of multiple sclerosis (MS) is welcome news for the company after suffering a major setback in 2022 when the FDA extended its review of Briumvi by three months.
. — Watch the episode here Listen to the podcast here Enterprising Yourself At The Top Of The Spine Distributorship Game With Daniel Tighe In this episode, we have with us another special guest, and he goes by the name of Daniel Tighe. They compete in one of the most competitive markets that we have. Keep giving me new stuff.
A narrow FDA AdComm vote in favor of accelerated approval for Sarepta’s first-in-class gene transfer therapy illustrates challenges faced by regulators, payers and developers as a wave of innovative genetic treatments for rare diseases comes to market.
Before 2020, the landscape of drug marketing involved following drug approvals by the Food and Drug Administration ( FDA ), finding which patient population would benefit from therapy, and visiting specialized doctors in-person to advertise its advantages compared to current guidelines.
The most important challenges that the profession will have to face are the following: Increased competition and consolidation of the healthcare industry: Due to an ever-growing demand for medical products, new entrants and established players compete fiercely for higher market shares. appeared first on MaBiCo.
With Sean Pitts We have with us another special guest, and he goes by the name of Sean Pitts. We may not be aware of that next-gen situation, or perhaps it’s a competitive situation or what have you. A lot of times, these are very confidential programs because their competition is so fierce. It’s pretty competitive.
Heres how programmatic display ads provide a competitive edge: 1. Compliance-Ready Advertising Pharma marketers must ensure their campaigns adhere to FDA and HIPAA regulations while still being effective. Pharma brands that embrace these strategies will stay ahead in an increasingly competitive industry.
Pediatric healthcare innovation companies—especially those in AR/VR/XR, Digital Therapeutics (“DTx”), Remote Monitoring, Virtual Care Management, Telehealth, and Telebehavioral health—need a deep understanding of the laws and regulations that govern this special market. Want to tackle these legal hurdles with confidence?
Why PPC is Essential for Pharma Marketing The pharma industry operates in a highly regulated and competitive space. Compliance-Ready Ad Strategies Pharma PPC campaigns must comply with FDA, HIPAA, and Googles healthcare advertising policies. PPC provides the tools to navigate compliance while reaching the right audience effectively.
Addimmune , which is exploring gene therapy technologies that treat and cure HIV, went the special purpose acquisition company (SPAC) route where a publicly traded company is created for the purpose of acquiring or merging with an existing company. These approaches helped in securing the $11M capital raise in September.
Specialized Certifications Specialized certifications can demonstrate a medical sales representative’s expertise and commitment to the industry. Skill Set Mastery Mastering the following skills can turn a regular medical sales representative into a successful one in this competitive field.
Key traits to look for in medical sales reps: Strong communication skills Adaptability to changing markets A deep understanding of medical device sales strategies Problem-solving abilities Self-motivation and resilience Recruitment strategies include networking at industry events, leveraging LinkedIn , and working with specialized recruiters.
Specializations: A cardiologist may respond differently to marketing for a heart failure treatment than a general practitioner. Solution: Partner with legal and compliance teams to ensure all campaigns adhere to FDA and HIPAA guidelines. Education and Training: Provide resources like webinars or white papers to engage HCPs effectively.
Since the inception of the clinical specialization, the orthopedic industry has relied on reusable surgical instrumentation. Quite recently, the Food and Drug Administration (FDA) marked a historical moment when it approved Patient Specific Talus Spacer 3D-printed implants in 2021. However, some specific trends demand a closer look.
Keep reading for top marketing strategies healthcare startups can implement to help them stand out in a competitive market. Highlight Approvals Clearly display any regulatory approvals, such as FDA clearance, to build credibility and trust. Regulatory compliance is a significant concern in the healthcare industry.
In this episode, Samuel Adeyinka interviews Pat Kothe , founder of a company specializing in medical devices for healing abscesses. He went on to be a founder of a company that specializes in a device that helps with the healing of abscesses but I’m not going to say anymore. I’ve got an FDA issue.”
— Watch the episode here Listen to the podcast here What A Field Clinical Engineer In Neuromodulation Sales Does With Blake Williams We have with us another special guest and he goes by the name of Blake Williams. FDA is happy with all of our results and our DMs are expressing that the physicians are happy with how everything is going.
B2B sales consulting for medical sales is a specialized service that helps healthcare organizations navigate the unique challenges of B2B transactions within the healthcare industry. These consultants provide tailored strategies to address specific challenges and objectives, offering a competitive edge.
— Watch the episode here Listen to the podcast here Selling Effectively In Medical Sales With John Crowder We have with us another special guest. You have to be able to talk about your product, especially in our field because it’s so governed by the FDA. Tune in now and get medical sales-ready! That is true.
Keeping abreast of the latest regulations, like FDA approvals and industry guidelines, ensures that you're not just a salesperson, but a trusted advisor to your clients. From social media platforms to e-detailing, the ability to navigate and capitalize on these digital landscapes can give you a significant edge in a competitive market.
With Edouard Saget In this episode, we have another special guest. What makes Edouard special? The negotiation with the hospital, the shipping across boundaries, frontiers, FDA, and non-FDA is very interesting. Sometimes my competition will take that article and say, “I could plus or minus 10 millimeters.”
12:24 – Jaclene Corstorphine (Guest) And there’s something really special about everybody on your team and all of your colleagues as sales reps. You know, I approach it like a competitive athlete. She also shares key insights on navigating the evolving medical sales landscape. We all were shareholders in the company, right.
12:24 – Jaclene Corstorphine (Guest) And there’s something really special about everybody on your team and all of your colleagues as sales reps. You know, I approach it like a competitive athlete. She also shares key insights on navigating the evolving medical sales landscape. We all were shareholders in the company, right.
A US Food and Drug Administration (FDA) Advisory Committee (AdCom) has voted unanimously in favour of giving HRA Pharma’s Opill (norgestrel) over-the-counter (OTC) availability. The FDA has no obligations to follow the recommendation of AdComs, though the vote will likely be weighed in the agency’s final decision.
In this special episode for Breast Cancer Awareness Month, Veronica Vasek uncovers the challenges, triumphs, and the vital role that diagnostic sales reps play in the healthcare landscape. It talks about FDA approval and I had my own personal experience. What does the competition look like in this space?
I am overjoyed to bring you a very special guest that goes by the name of Shirley Taylor. We have competition. Now you’re talking about FDA-compliant equipment in the hospital space. Tune in and learn what it takes to be one and thrive as one! — Watch the episode here. Listen to the podcast here. Are you budgeted?
Recently, the FDA announced a requirement for opioid analgesics manufacturers to make prepaid mail-back envelopes available to outpatient pharmacies and other dispensers. In a press release , acting Special Agent in Charge of the DEA’s New Jersey Division Daniel J. This will act as another safe disposal option for these drugs.
In a 2022 annual report, the US Food and Drug Administration’s (FDA) Office of Generic Drugs stated it had approved 106 first generics— the introductory generic competitors of branded drugs. Don’t miss the special thematic supplement that inspects the evolving role of cybersecurity in the pharmaceutical industry.
John Young, Pfizer’s Group President and Chief Business Officer kicked off the event with a fireside chat on the value of competitive collaboration in driving innovation and creating a roadmap to delivering important medicines to patients who need them. Find where stages of work have too much idle time or where tasks sit waiting for action.
China still hasn’t approved western mRNA vaccines, despite submission, and the US FDA rejects Chinese-only trial data for cancer medicines. Now, for major specialty care therapy areas, including Hepatis C, Immuno-oncology and HIV, there is a competitive launch nearly every year.
As competition intensifies, strategic marketing becomes the key differentiator, ensuring that companies not only survive but thrive. This highlights the necessity for highly targeted marketing strategies that cater to decision-makers in an increasingly competitive landscape. billion annually and projected to reach $1.3
12:24 – Jaclene Corstorphine (Guest) And there’s something really special about everybody on your team and all of your colleagues as sales reps. You know, I approach it like a competitive athlete. She also shares key insights on navigating the evolving medical sales landscape. We all were shareholders in the company, right.
48:12 What is Uri Gorenseeing that is special in the Israeli Digital Health ecosystem? So, you see on one side, there's a special body of the FDA trying to listen to patients to find new targets for health and for pharmaceutical technology. I think vaccines, in most cases, is a special case. I've been preaching for that.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content